Site Search
Displaying results 251 - 260 of 573
Resource | Reviews and Snapshots,
In the past 15 years, global progress against AIDS has been significant. Yet achievements have been unequal. Throughout the world, stigma, discrimination and exclusion, as well as imbalanced power and gender relations, continue to make women and girls, young people and key populations vulnerable to HIV and hinder access to HIV prevention, treatment and care services.
The AIDS response has demonstrated the importance and feasibility of overcoming human rights, gender-related and legal barriers to HIV services. The vision of zero discrimination put forward in the UNAIDS 2009–2015 Strategy and endorsed by the 2011 Political Declaration on HIV and AIDS has inspired action in advocacy, litigation and law reform for the right to health, including access to essential medicines.
Resource | Publications,
The global response to the HIV pandemic has been unprecedented. Billions of dollars and millions of people were quickly mobilized to save lives and fight the pandemic. The gains have been tremendous. If country governments, donors, and civil society work in partnership, and continue to ensure every investment has a clear outcome, it is within our grasp to control the epidemic. Yet, this potential success is at risk if we do not take decisive actions to ensure the HIV response is sustainable. A series of concrete actions are available that will have rapid impact and accelerate our progress towards long-term sustainability.
In 2015, PEPFAR took dramatic new steps to hardwire sustainability into its business processes, developing strategic approaches to move the sustainability agenda forward, and measure progress. This paper sets forth PEPFAR’s tactics to sustainably build national HIV responses and practices that monitor progress toward sustainable epidemic control and achievement of the global 90-90-90 goal.
Resource | Infographics,
The WHO World Antibiotic Awareness Week held from 14 to 20 November 2016. The campaign aims to increase awareness of global antibiotic resistance and to encourage best practices among the general public, health workers, policy-makers and the agriculture sector to avoid the further emergence and spread of antibiotic resistance.
Resource | Publications,
This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities need to identify the appropriate HCV treatment, and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome. It also provides information on the production of new hepatitis C drugs and generic versions worldwide, including where the drugs are registered, where the drugs are patented and where not, and what opportunities countries have under the license agreements that were signed by some companies as well as current pricing of all recommended DAAs, including by generic companies all over the world.
Resource | Publications,
The United Nations Secretary-General establish a high-level body to propose ways of incentivizing health technology innovation and increasing access to medicines and treatment, Secretary-General Ban Ki-moon, in November 2015, announced the appointment of a High-Level Panel on Innovation and Access to Health Technologies.
According to a High-Level Panel convened to advise the UN Secretary-General on improving access to medicines, the world must take bold new approaches to both health technology innovation and ensuring access so that all people can benefit from the medical advances that have dramatically improved the lives of millions around the world in the last century.
Resource | Publications,
The number of people receiving antiretroviral therapy (ART) in low- and middle-income countries continues to show promising growth, indicating that the global effort to scale up HIV treatment has exceeded 15 million people by the end of 2015. As of the end of 2015, the number of people receiving ART had reached 15.9 million in low- and middle-income countries, indicating a stable annual growth rate of 1.8 million per year since 2012.
The goal of this report is to provide countries and suppliers with estimates of the global market for antiretroviral (ARV) medicines in low- and middle-income countries for 2015–2020. The report includes estimates of the global demand for both active pharmaceutical ingredients and ARV formulations to enable suppliers to manage their manufacturing capacity accordingly.
Resource | Laws and Policies,
Antimicrobial resistance (AMR) has become one of the biggest threats to global health and endangers other major priorities, such as human development. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in longer illnesses and more deaths. At the same time, not enough new antimicrobial drugs, especially antibiotics, are being developed to replace older and increasingly ineffective ones.
Global leaders will meet at the United Nations General Assembly in New York in September 2016 to commit to fighting antimicrobial resistance together. This is only the fourth time in the history of the UN that a health topic is discussed at the General Assembly (HIV, noncommunicable diseases, and Ebola were the others). Heads of State and Heads of Delegations are expected to address the seriousness and scope of the situation and to agree on sustainable, multisectoral approaches to addressing antimicrobial resistance.
General Assembly of the United Nations: High-level Meeting programme
Fact sheet on AMR
Resource | Publications,
The 10th Asia-Pacific United Nations Prevention of Parent-To-Child Transmission (PPTCT) of HIV and Syphilis Task Force meeting was held from 15 to 17 September 2015 in Beijing, China. More than 230 participants from 19 Asia-Pacific countries, including 90 participants from provinces in China, as well as civil society and United Nations partners attended the meeting. The meeting focused on steps towards achieving and validating the elimination of parent-to-child transmission (EPTCT) of infectious diseases, and the integration of services to contribute to improving maternal and child health (MCH) outcomes.
Resource | Publications,
The dual goals of elimination of parent-to-child transmission (EPTCT) of HIV and syphilis areaspirational, although challenging for countries to achieve. The adoption of these goals – and for some countries triple elimination with the inclusion of screening for the hepatitis B virus (HBV) – has been instrumental to efforts to meet MDG 6. They are also important to realizing the health-related targets of the Sustainable Development Goals (SDGs), adopted by the international community in September 2015.
Resource | Fact Sheets,
Background:
- Comprehensive PMTCT service started in Nepal in February 2005.
- Community-based PMTCT (CB-PMTCT) program is expanded in 55 districts (Global Fund: 32 districts, UNICEF: 14 districts and GoN: 9 districts) where HIV screening and counseling is done among every ANC visitors at the district.
- Free ARV drugs are available from 65 ART sites in 59 districts from where HIV-positive mothers can receive treatment.
- Early Infant Diagnosis (EID) service is available for babies born to the HIV-positive mothers.